Aged nasal epithelium is more prone to severe COVID-19

Ivan Zanoni

DOI: https://doi.org/10.1038/s41590-024-01824-x

IF: 30.5

2024-04-19

Nature Immunology

Abstract:Age is the single greatest risk factor driving mortality after encounter with SARS-CoV-2. A new study shows that the composition of nasal epithelial cells varies across ages, facilitating SARS-CoV-2 growth and spread in older people.

immunology

What problem does this paper attempt to address?

Immune cell residency in the nasal mucosa may partially explain respiratory disease severity across the age range

Konner Winkley,Dithi Banerjee,Todd Bradley,Boryana Koseva,Warren A. Cheung,Rangaraj Selvarangan,Tomi Pastinen,Elin Grundberg

DOI: https://doi.org/10.1038/s41598-021-95532-3

IF: 4.6

2021-08-05

Scientific Reports

Abstract:Abstract Previous studies focusing on the age disparity in COVID-19 severity have suggested that younger individuals mount a more robust innate immune response in the nasal mucosa after infection with SARS-CoV-2. However, it is unclear if this reflects increased immune activation or increased immune residence in the nasal mucosa. We hypothesized that immune residency in the nasal mucosa of healthy individuals may differ across the age range. We applied single-cell RNA-sequencing and measured the cellular composition and transcriptional profile of the nasal mucosa in 35 SARS-CoV-2 negative children and adults, ranging in age from 4 months to 65 years. We analyzed in total of ~ 30,000 immune and epithelial cells and found that age and immune cell proportion in the nasal mucosa are inversely correlated, with little evidence for structural changes in the transcriptional state of a given cell type across the age range. Orthogonal validation by epigenome sequencing indicate that it is especially cells of the innate immune system that underlie the age-association. Additionally, we characterize the predominate immune cell type in the nasal mucosa: a resident T cell like population with potent antiviral properties. These results demonstrate fundamental changes in the immune cell makeup of the uninfected nasal mucosa over the lifespan. The resource we generate here is an asset for future studies focusing on respiratory infection and immunization strategies.

multidisciplinary sciences
Age-specific nasal epithelial responses to SARS-CoV-2 infection

Maximillian N. J. Woodall,Ana-Maria Cujba,Kaylee B. Worlock,Katie-Marie Case,Tereza Masonou,Masahiro Yoshida,Krzysztof Polanski,Ni Huang,Rik G. H. Lindeboom,Lira Mamanova,Liam Bolt,Laura Richardson,Batuhan Cakir,Samuel Ellis,Machaela Palor,Thomas Burgoyne,Andreia Pinto,Dale Moulding,Timothy D. McHugh,Aarash Saleh,Eliz Kilich,Puja Mehta,Chris O’Callaghan,Jie Zhou,Wendy Barclay,Paolo DeCoppi,Colin R. Butler,Mario Cortina-Borja,Heloise Vinette,Sunando Roy,Judith Breuer,Rachel C. Chambers,Wendy E. Heywood,Kevin Mills,Robert E. Hynds,Sarah A. Teichmann,Kerstin B. Meyer,Marko Z. Nikolić,Claire M. Smith

DOI: https://doi.org/10.1038/s41564-024-01658-1

IF: 28.3

2024-04-16

Nature Microbiology

Abstract:Children infected with SARS-CoV-2 rarely progress to respiratory failure. However, the risk of mortality in infected people over 85 years of age remains high. Here we investigate differences in the cellular landscape and function of paediatric ( 70 years) ex vivo cultured nasal epithelial cells in response to infection with SARS-CoV-2. We show that cell tropism of SARS-CoV-2, and expression of ACE2 and TMPRSS2 in nasal epithelial cell subtypes, differ between age groups. While ciliated cells are viral replication centres across all age groups, a distinct goblet inflammatory subtype emerges in infected paediatric cultures and shows high expression of interferon-stimulated genes and incomplete viral replication. In contrast, older adult cultures infected with SARS-CoV-2 show a proportional increase in basaloid-like cells, which facilitate viral spread and are associated with altered epithelial repair pathways. We confirm age-specific induction of these cell types by integrating data from in vivo COVID-19 studies and validate that our in vitro model recapitulates early epithelial responses to SARS-CoV-2 infection.

microbiology
SARS-CoV-2, COVID-19 and the aging immune system

Juliet M. Bartleson,Dina Radenkovic,Anthony J. Covarrubias,David Furman,Daniel A. Winer,Eric Verdin

DOI: https://doi.org/10.1038/s43587-021-00114-7

2021-09-01

Nature Aging

Abstract:Nature Aging, Published online: 14 September 2021; doi:10.1038/s43587-021-00114-7COVID-19 causes high mortality in older adults compared to younger people. Bartleson et al. review the immunological mechanisms that make older adults vulnerable to COVID-19 and discuss ways to bolster immunity in this population during COVID-19.

English Else
Role of Aging and the Immune Response to Respiratory Viral Infections: Potential Implications for COVID-19

Judy Chen,William J Kelley,Daniel R Goldstein,William J. Kelley,Daniel R. Goldstein

DOI: https://doi.org/10.4049/jimmunol.2000380

2020-06-03

The Journal of Immunology

Abstract:Aging impairs immunity to promote diseases, especially respiratory viral infections. The current COVID-19 pandemic, resulting from SARS-CoV-2, induces acute pneumonia, a phenotype that is alarmingly increased with aging. In this article, we review findings of how aging alters immunity to respiratory viral infections to identify age-impacted pathways common to several viral pathogens, permitting us to speculate about potential mechanisms of age-enhanced mortality to COVID-19. Aging generally leads to exaggerated innate immunity, particularly in the form of elevated neutrophil accumulation across murine and large animal studies of influenza infection. COVID-19 patients who succumb exhibit a 2-fold increase in neutrophilia, suggesting that exaggerated innate immunity contributes to age-enhanced mortality to SARS-CoV-2 infection. Further investigation in relevant experimental models will elucidate the mechanisms by which aging impacts respiratory viral infections, including SARS-CoV-2. Such investigation could identify therapies to reduce the suffering of the population at large, but especially among older people, infected with respiratory viruses.

immunology
Aging, inflammaging and immunosenescence as risk factors of severe COVID-19

DOI: https://doi.org/10.1186/s12979-022-00309-5

2022-11-12

Abstract:Coronavirus disease 2019 (COVID-19) is a respiratory infectious disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is characterized by having a heterogeneous disease course, ranging from asymptomatic and mild symptoms to more severe and critical cases. In most cases the severity of COVID-19 is related to host factors, especially deregulation of the immune response in patients. Even if COVID-19 indiscriminately affects individuals of different age group, ethnicity and economic status; most severe cases and disproportional mortality occur in elderly individuals. This point out that aging is one risk factor for unfavourable clinical outcomes among COVID-19 patients. The biology of aging is a complex process; Aging can alter the structure and function of cells, tissues, and organs resulting in impaired response to stress. Alongside with other systems, the immune system is also affected with the aging process. Immunosenescence is an age associated change in the immune system that affects the overall response to immunological challenges in the elderly. Similarly, apart from the normal inflammatory process, aging is associated with a low grade, sterile, chronic inflammation which is termed as inflammaging. We hypothesized that inflammaging and immunosenescence could play an important role in SARS-CoV-2 pathogenesis and poor recovery from COVID-19 in elderly individuals. This review summarizes the changes in the immune system with age and how these changes play part in the pathogenesis of SARS-CoV-2 and clinical outcome of COVID-19 which could add to the understanding of age associated targeted immunotherapy in the elderly.

immunology,geriatrics & gerontology,gerontology
Age-related Differences in the Nasal Mucosal Immune Response to SARS-CoV-2

Clarissa M Koch,Andrew D Prigge,Kishore R Anekalla,Avani Shukla,Hanh Chi Do Umehara,Leah Setar,Jairo Chavez,Hiam Abdala-Valencia,Yuliya Politanska,Nikolay S Markov,Grant R Hahn,Taylor Heald-Sargent,L Nelson Sanchez-Pinto,William J Muller,Benjamin D Singer,Alexander V Misharin,Karen M Ridge,Bria M Coates

DOI: https://doi.org/10.1165/rcmb.2021-0292OC

Abstract:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than 180 million people since the onset of the pandemic. Despite similar viral load and infectivity rates between children and adults, children rarely develop severe illness. Differences in the host response to the virus at the primary infection site are among the mechanisms proposed to account for this disparity. Our objective was to investigate the host response to SARS-CoV-2 in the nasal mucosa in children and adults and compare it with the host response to respiratory syncytial virus (RSV) and influenza virus. We analyzed clinical outcomes and gene expression in the nasal mucosa of 36 children with SARS-CoV-2, 24 children with RSV, 9 children with influenza virus, 16 adults with SARS-CoV-2, and 7 healthy pediatric and 13 healthy adult controls. In both children and adults, infection with SARS-CoV-2 led to an IFN response in the nasal mucosa. The magnitude of the IFN response correlated with the abundance of viral reads, not the severity of illness, and was comparable between children and adults infected with SARS-CoV-2 and children with severe RSV infection. Expression of ACE2 and TMPRSS2 did not correlate with age or presence of viral infection. SARS-CoV-2-infected adults had increased expression of genes involved in neutrophil activation and T-cell receptor signaling pathways compared with SARS-CoV-2-infected children, despite similar severity of illness and viral reads. Age-related differences in the immune response to SARS-CoV-2 may place adults at increased risk of developing severe illness.
SARS-CoV-2 infection represents a high risk for the elderly: analysis of pathogenesis

Adriana Pedreañez,Jesus Mosquera-Sulbaran,Nelson Muñoz

DOI: https://doi.org/10.1007/s00705-021-05042-w

IF: 2.685

2021-03-22

Archives of Virology

Abstract:As people get older, age-related alterations occur that lead to increased susceptibility to disease. In the current COVID-19 pandemic, older people are particularly susceptible to a SARS-CoV-2 infection developing into severe disease. The objective of this review was to examine the literature regarding factors that may explain the tendency of this population to develop severe COVID-19. Research articles considered in this review were searched for in EMBASE, PubMed, and Web of Science from December 2019 to December 2020. Citations were screened by two independent reviewers. Studies of the immune system in older individuals found alterations in both the adaptive and innate immune systems. The adaptive system is depressed in its functions, and the innate system is in a pro-inflammatory state that can lead to chronic disease. This pro-inflammatory state may be related to a severe course of disease in COVID-19. This review shows that the level of evidence supporting an association between immune alterations in the elderly and susceptibly to severe progression of SARS-CoV-2 infection is generally consistent. Preventive measures such as early antiviral treatment are of key importance for prevention of severe progression of COVID19.

virology
COVID‐19 is an emergent disease of aging

Didac Santesmasses,José Pedro Castro,Aleksandr A. Zenin,Anastasia V. Shindyapina,Maxim V. Gerashchenko,Bohan Zhang,Csaba Kerepesi,Sun Hee Yim,Peter O. Fedichev,Vadim N. Gladyshev

DOI: https://doi.org/10.1111/acel.13230

IF: 11.005

2020-10-01

Aging Cell

Abstract:<p>COVID‐19 is an ongoing pandemic caused by the SARS‐CoV‐2 coronavirus that poses one of the greatest challenges to public health in recent years. SARS‐CoV‐2 is known to preferentially target older subjects and those with pre‐existing conditions, but the reason for this age dependence is unclear. Here, we found that the case fatality rate for COVID‐19 grows exponentially with age in all countries tested, with the doubling time approaching that of all‐cause human mortality. In addition, men and those with multiple age‐related diseases are characterized by increased mortality. Moreover, similar mortality patterns were found for all‐cause pneumonia. We further report that the gene expression of ACE2, the SARS‐CoV‐2 receptor, grows in the lung with age, except for subjects on a ventilator. Together, our findings establish COVID‐19 as an emergent disease of aging, and age and age‐related diseases as its major risk factors. In turn, this suggests that COVID‐19, and deadly respiratory diseases in general, may be targeted, in addition to antiviral approaches, by approaches that target the aging process.</p>

cell biology,geriatrics & gerontology
Aging is associated with an insufficient early inflammatory response of lung endothelial cells in SARS-CoV-2 infection

Saravanan Subramaniam,Devin Kenney,Archana Jayaraman,Aoife Kateri O'Connell,Sarah Walachowski,Paige Montanaro,Christoph Reinhardt,Giuseppe Colucci,Nicholas A. Crossland,Florian Douam,Markus Bosmann

DOI: https://doi.org/10.3389/fimmu.2024.1397990

IF: 7.3

2024-06-08

Frontiers in Immunology

Abstract:Advanced age is associated with an increased susceptibility to Coronavirus Disease (COVID)-19 and more severe outcomes, although the underlying mechanisms are understudied. The lung endothelium is located next to infected epithelial cells and bystander inflammation may contribute to thromboinflammation and COVID-19-associated coagulopathy. Here, we investigated age-associated SARS-CoV-2 pathogenesis and endothelial inflammatory responses using humanized K18-hACE2 mice. Survival was reduced to 20% in aged mice (85–112 weeks) versus 50% in young mice (12–15 weeks) at 10 days post infection (dpi). Bulk RNA-sequencing of endothelial cells from mock and infected mice at 2dpi of both age groups (aged: 72–85 weeks; young: 15 weeks) showed substantially lower significant differentially regulated genes in infected aged mice than in young mice (712 versus 2294 genes). Viral recognition and anti-viral pathways such as RIG-I-like receptor signaling, NOD-like receptor signaling and interferon signaling were regulated in response to SARS-CoV-2. Young mice showed several fold higher interferon responses ( Ifitm3 , Ifit1 , Isg15, Stat1 ) and interferon-induced chemokines ( Cxcl10 and Cxcl11 ) than aged mice. Endothelial cells from infected young mice displayed elevated expression of chemokines ( Cxcl9 , Ccl2 ) and leukocyte adhesion markers ( Icam1 ) underscoring that inflammation of lung endothelium during infection could facilitate leukocyte adhesion and thromboinflammation. TREM1 and acute phase response signaling were particularly prominent in endothelial cells from infected young mice. Immunohistochemistry was unable to detect viral protein in pulmonary endothelium. In conclusion, our data demonstrate that the early host response of the endothelium to SARS-CoV-2 infection declines with aging, which could be a potential contributor to disease severity.

immunology
Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?

Varnica Bajaj,Nirupa Gadi,Allison P. Spihlman,Samantha C. Wu,Christopher H. Choi,Vaishali R. Moulton

DOI: https://doi.org/10.3389/fphys.2020.571416

IF: 4

2021-01-12

Frontiers in Physiology

Abstract:The novel coronavirus severe acute respiratory syndrome coronavirus 2 causing the Coronavirus disease (COVID-19) pandemic has ravaged the world with over 72 million total cases and over 1.6 million deaths worldwide as of early December 2020. An overwhelming preponderance of cases and deaths is observed within the elderly population, and especially in those with pre-existing conditions and comorbidities. Aging causes numerous biological changes in the immune system, which are linked to age-related illnesses and susceptibility to infectious diseases. Age-related changes influence the host immune response and therefore not only weaken the ability to fight respiratory infections but also to mount effective responses to vaccines. Immunosenescence and inflamm-aging are considered key features of the aging immune system wherein accumulation of senescent immune cells contribute to its decline and simultaneously increased inflammatory phenotypes cause immune dysfunction. Age-related quantitative and qualitative changes in the immune system affect cells and soluble mediators of both the innate and adaptive immune responses within lymphoid and non-lymphoid peripheral tissues. These changes determine not only the susceptibility to infections, but also disease progression and clinical outcomes thereafter. Furthermore, the response to therapeutics and the immune response to vaccines are influenced by age-related changes within the immune system. Therefore, better understanding of the pathophysiology of aging and the immune response will not only help understand age-related diseases but also guide targeted management strategies for deadly infectious diseases like COVID-19.

physiology
Changes in the innate immune response to SARS-CoV-2 with advancing age in humans

Sudhanshu Agrawal,Michelle Thu Tran,Tara Sinta Kartika Jennings,Marlaine Maged Hosny Soliman,Sally Heo,Bobby Sasson,Farah Rahmatpanah,Anshu Agrawal

DOI: https://doi.org/10.1186/s12979-024-00426-3

2024-03-22

Immunity & Ageing

Abstract:Advancing age is a major risk factor for respiratory viral infections. The infections are often prolonged and difficult to resolve resulting hospitalizations and mortality. The recent COVID-19 pandemic has highlighted this as elderly subjects have emerged as vulnerable populations that display increased susceptibility and severity to SARS-CoV-2. There is an urgent need to identify the probable mechanisms underlying this to protect against future outbreaks of such nature. Innate immunity is the first line of defense against viruses and its decline impacts downstream immune responses. This is because dendritic cells (DCs) and macrophages are key cellular elements of the innate immune system that can sense and respond to viruses by producing inflammatory mediators and priming CD4 and CD8 T-cell responses.

immunology,geriatrics & gerontology,gerontology
Aging shapes infection profiles of influenza A virus and SARS-CoV-2 in human lung slices

Melanie Brügger,Carlos Machahua,Beatrice Zumkehr,Christiana Cismaru,Damian Jandrasits,Patrick Dorn,Thomas M. Marti,Gert Zimmer,Volker Thiel,Manuela Funke-Chambour,Marco P. Alves

DOI: https://doi.org/10.1101/2024.04.14.589423

2024-04-16

Abstract:The recent coronavirus disease 2019 (COVID-19) outbreak revealed the susceptibility of elderly patients to respiratory virus infections, showing cell senescence or subclinical persistent inflammatory profiles and favouring the development of severe pneumonia. In our study, we evaluated the potential influence of lung aging on the efficiency of replication of influenza A virus (IAV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as well as determined the pro-inflammatory and antiviral responses of the distal lung tissue. Using precision-cut lung slices (PCLS) from donors of different ages, we found that pandemic H1N1 and avian H5N1 IAV replicated in the lung parenchyma with high efficacy. In contrast to these IAV strains, SARS-CoV-2 early isolate and Delta variant of concern (VOC) replicated less efficiently in PCLS. Interestingly, both viruses showed reduced replication in PCLS from older compared to younger donors, suggesting that aged lung tissue represents a sub-optimal environment for viral replication. Regardless of the age-dependent viral loads, PCLS responded to infection with both viruses by an induction of IL-6 and IP-10/CXCL10 mRNAs, being highest for H5N1. Finally, while SARS-CoV-2 infection was not causing detectable cell death, IAV infection caused significant cytotoxicity and induced significant early interferon responses. In summary, our findings suggest that aged lung tissue might not favour viral dissemination, pointing to a determinant role of dysregulated immune mechanisms in the development of severe disease.

Microbiology
Why does COVID-19 disproportionately affect older people?

Amber L Mueller,Maeve S McNamara,David A Sinclair,Amber L. Mueller,Maeve S. McNamara,David A. Sinclair

DOI: https://doi.org/10.18632/aging.103344

2020-05-29

Aging

Abstract:The severity and outcome of coronavirus disease 2019 (COVID-19) largely depends on a patient's age. Adults over 65 years of age represent 80% of hospitalizations and have a 23-fold greater risk of death than those under 65. In the clinic, COVID-19 patients most commonly present with fever, cough and dyspnea, and from there the disease can progress to acute respiratory distress syndrome, lung consolidation, cytokine release syndrome, endotheliitis, coagulopathy, multiple organ failure and death. Comorbidities such as cardiovascular disease, diabetes and obesity increase the chances of fatal disease, but they alone do not explain why age is an independent risk factor. Here, we present the molecular differences between young, middle-aged and older people that may explain why COVID-19 is a mild illness in some but life-threatening in others. We also discuss several biological age clocks that could be used in conjunction with genetic tests to identify both the mechanisms of the disease and individuals most at risk. Finally, based on these mechanisms, we discuss treatments that could increase the survival of older people, not simply by inhibiting the virus, but by restoring patients' ability to clear the infection and effectively regulate immune responses.
Immune cell population and cytokine profiling suggest age dependent differences in the response to SARS-CoV-2 infection

Larraitz Aragon,Andrea Iribarren-López,Ainhoa Alberro,Leire Iparraguirre,Miguel Von Wichmann,Jose María Marimon,Nagore Saiz-Calderon,Julia Agudo,M. Isabel Gálvez,M. Carmen Cipitria,Alvaro Prada,David Otaegui

DOI: https://doi.org/10.3389/fragi.2023.1108149

2023-02-13

Frontiers in Aging

Abstract:Aging population is at higher risk of developing severe COVID-19, including hospitalization and death. In this work, to further understand the relationship between host age-related factors, immunosenescence/exhaustion of the immune system and the response to the virus, we characterized immune cell and cytokine responses in 58 COVID-19 patients admitted to the hospital and 40 healthy controls of different age ranges. Lymphocyte populations and inflammatory profiles were studied in blood samples, using different panels of multicolor flow cytometry. As expected, our analysis reveals differences at both the cellular and cytokine level in COVID-19 patients. Interestingly, when the age range analysis was carried out, the immunological response to the infection was found to differ with age, being especially affected in the group of 30–39 years. In this age range, an increased exhausted T cell response and a decrease of naïve T helper lymphocytes was found in patients, as well as a reduced concentration of the proinflammatory TNF, IL-1β and IL-8 cytokines. Besides, the correlation between age and the study variables was evaluated, and multiple cell types and interleukins were found to correlate with donor age. Notably, the correlations of T helper naïve and effector memory cells, T helper 1–17 cells, TNF, IL-10, IL-1β, IL-8, among others, showed differences between healthy controls and COVID-19 patients. Our findings, in the context of other previous studies, suggest that aging affects the behavior of the immune system in COVID-19 patients. They suggest that young individuals are able to mount an initial response to SARS-CoV-2, but some of them present an accelerated exhaustion of the cell response and an insufficient inflammatory response, resulting in a moderate to severe COVID-19. On the other hand, in older patients there is a smaller immune cell response to the virus, reflected in fewer differences in immune populations between COVID-19 patients and controls. Nevertheless, old patients show more evidence of an inflammatory phenotype, suggesting that the underlying inflammation associated with their age is exacerbated by the SARS-CoV-2 infection.
Why Does the Severity of COVID-19 Differ With Age?: Understanding the Mechanisms Underlying the Age Gradient in Outcome Following SARS-CoV-2 Infection

Petra Zimmermann,Nigel Curtis

DOI: https://doi.org/10.1097/INF.0000000000003413

2022-02-01

Abstract:Although there are many hypotheses for the age-related difference in the severity of COVID-19, differences in innate, adaptive and heterologous immunity, together with differences in endothelial and clotting function, are the most likely mechanisms underlying the marked age gradient. Children have a faster and stronger innate immune response to SARS-CoV-2, especially in the nasal mucosa, which rapidly controls the virus. In contrast, adults can have an overactive, dysregulated and less effective innate response that leads to uncontrolled pro-inflammatory cytokine production and tissue injury. More recent exposure to other viruses and routine vaccines in children might be associated with protective cross-reactive antibodies and T cells against SARS-CoV-2. There is less evidence to support other mechanisms that have been proposed to explain the age-related difference in outcome following SARS-CoV-2 infection, including pre-existing immunity from exposure to common circulating coronaviruses, differences in the distribution and expression of the entry receptors ACE2 and TMPRSS2, and difference in viral load.
Environmentally persistent free radicals enhance SARS-CoV-2 replication in respiratory epithelium

Ayaho Yamamoto,Peter D Sly,Keng Yih Chew,Lavrent Khachatryan,Nelufa Begum,Abrey J Yeo,Luan D Vu,Kirsty R Short,Stephania A Cormier,Emmanuelle Fantino

DOI: https://doi.org/10.1177/15353702221142616

2023-01-13

Experimental Biology and Medicine

Abstract:Experimental Biology and Medicine, Ahead of Print. Epidemiological evidence links lower air quality with increased incidence and severity of COVID-19; however, mechanistic data have yet to be published. We hypothesized air pollution-induced oxidative stress in the nasal epithelium increased viral replication and inflammation. Nasal epithelial cells (NECs), collected from healthy adults, were grown into a fully differentiated epithelium. NECs were infected with the ancestral strain of SARS-CoV-2. An oxidant combustion by-product found in air pollution, the environmentally persistent free radical (EPFR) DCB230, was used to mimic pollution exposure four hours prior to infection. Some wells were pretreated with antioxidant, astaxanthin, for 24 hours prior to EPFR-DCB230 exposure and/or SARS-CoV-2 infection. Outcomes included viral replication, epithelial integrity, surface receptor expression (ACE2, TMPRSS2), cytokine mRNA expression (TNF-α, IFN-β), intracellular signaling pathways, and oxidative defense enzymes. SARS-CoV-2 infection induced a mild phenotype in NECs, with some cell death, upregulation of the antiviral cytokine IFN-β, but had little effect on intracellular pathways or oxidative defense enzymes. Prior exposure to EPFR-DCB230 increased SARS-CoV-2 replication, upregulated TMPRSS2 expression, increased secretion of the proinflammatory cytokine TNF-α, inhibited expression of the mucus producing MUC5AC gene, upregulated expression of p21 (apoptosis pathway), PINK1 (mitophagy pathway), and reduced levels of antioxidant enzymes. Pretreatment with astaxanthin reduced SARS-CoV-2 replication, downregulated ACE2 expression, and prevented most, but not all EPFR-DCB230 effects. Our data suggest that oxidant damage to the respiratory epithelium may underly the link between poor air quality and increased COVID-19. The apparent protection by antioxidants warrants further research.

medicine, research & experimental
Evidence That SARS-CoV-2 Induces Lung Cell Senescence: Potential Impact on COVID-19 Lung Disease

Larissa Lipskaia,Pauline Maisonnasse,Charles Fouillade,Valentin Sencio,Quentin Pascal,Jean-Michel Flaman,Emmanuelle Born,Arturo Londono-Vallejo,Roger Le Grand,David Bernard,François Trottein,Serge Adnot

DOI: https://doi.org/10.1165/rcmb.2021-0205LE

IF: 7.748

2022-01-01

American Journal of Respiratory Cell and Molecular Biology

Abstract:To the Editor : Older age is a major risk factor for severe coronavirus disease (COVID-19) (1). Understanding the biological mechanisms linking age to the pathogenesis of COVID-19 is essential for developing preventive and therapeutic strategies. We hypothesized that cell senescence, a basic aging process that plays a pivotal role in health deterioration and diseases, particularly those targeting the lung (2), is involved in the pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–induced lung disease, including the development of long-lasting lung alterations. Senescent cells exhibit a stable proliferation arrest and acquire a specific senescence-associated secretory phenotype characterized by the release of inflammatory cytokines, immune modulators, proteases, profibrotic factors, and various effectors that can alter tissue organization and function (3). Senescence is triggered by a myriad of stressors that promote a DNA damage response leading to p53-dependent upregulation of the CDK inhibitor p21 and/or expression of p16, which is used as a reliable marker of senescent cells. Cell senescence is pivotal in age-associated lung diseases, notably lung emphysema, fibrosis, and chronic obstructive pulmonary disease (2, 4–6). In recent studies, SARS-CoV-2 Spike protein-1 was shown to exacerbate the senescence-associated secretory phenotype of human senescent cells, thereby contributing to the exuberant inflammatory response seen in severe COVID-19. Targeting senescent cells using senolytic drugs reduced mortality in old mice infected with a mouse β-coronavirus (7). To further evaluate potential links between SARS-CoV-2 infection and cell senescence, we analyzed publicly available single-cell RNA sequencing data sets obtained using BAL fluid (BALF) cells from patients with moderate or severe-to-critical COVID-19 (8). We also monitored lung cell senescence in SARS-CoV-2–infected macaques, which constitute a relevant model for studying human COVID-19 (9).

biochemistry & molecular biology,cell biology,respiratory system
Host-Microbe Multiomic Profiling Reveals Age-Dependent COVID-19 Immunopathology

Hoang Van Phan,Alexandra Tsitsiklis,Cole P. Maguire,Elias K. Haddad,Patrice M. Becker,Seunghee Kim-Schulze,Brian Lee,Jing Chen,Annmarie Hoch,Harry Pickering,Patrick Van Zalm,Matthew C. Altman,Alison D. Augustine,Carolyn S. Calfee,Steve Bosinger,Charles Cairns,Walter Eckalbar,Leying Guan,Naresh Doni Jayavelu,Steven H. Kleinstein,Florian Krammer,Holden T. Maecker,Al Ozonoff,Bjoern Peters,Nadine Rouphael,IMPACC Network,Ruth R. Montgomery,Elaine Reed,Joanna Schaenman,Hanno Steen,Ofer Levy,Joann Diray-Arce,Charles R. Langelier

DOI: https://doi.org/10.1101/2024.02.11.24301704

2024-02-13

Abstract:Age is a major risk factor for severe coronavirus disease-2019 (COVID-19), yet the mechanisms responsible for this relationship have remained incompletely understood. To address this, we evaluated the impact of aging on host and viral dynamics in a prospective, multicenter cohort of 1,031 patients hospitalized for COVID-19, ranging from 18 to 96 years of age. We performed blood transcriptomics and nasal metatranscriptomics, and measured peripheral blood immune cell populations, inflammatory protein expression, anti-SARS-CoV-2 antibodies, and anti-interferon (IFN) autoantibodies. We found that older age correlated with an increased SARS-CoV-2 viral load at the time of admission, and with delayed viral clearance over 28 days. This contributed to an age-dependent increase in type I IFN gene expression in both the respiratory tract and blood. We also observed age-dependent transcriptional increases in peripheral blood IFN-(, neutrophil degranulation, and Toll like receptor (TLR) signaling pathways, and decreases in T cell receptor (TCR) and B cell receptor signaling pathways. Over time, older adults exhibited a remarkably sustained induction of proinflammatory genes (e.g., CXCL6) and serum chemokines (e.g., CXCL9) compared to younger individuals, highlighting a striking age-dependent impairment in inflammation resolution. Augmented inflammatory signaling also involved the upper airway, where aging was associated with upregulation of TLR, IL17, type I IFN and IL1 pathways, and downregulation TCR and PD-1 signaling pathways. Metatranscriptomics revealed that the oldest adults exhibited disproportionate reactivation of herpes simplex virus and cytomegalovirus in the upper airway following hospitalization. Mass cytometry demonstrated that aging correlated with reduced naïve T and B cell populations, and increased monocytes and exhausted natural killer cells. Transcriptional and protein biomarkers of disease severity markedly differed with age, with the oldest adults exhibiting greater expression of TLR and inflammasome signaling genes, as well as proinflammatory proteins (e.g., IL6, CXCL8), in severe COVID-19 compared to mild/moderate disease. Anti-IFN autoantibody prevalence correlated with both age and disease severity. Taken together, this work profiles both host and microbe in the blood and airway to provide fresh insights into aging-related immune changes in a large cohort of vaccine-naïve COVID-19 patients. We observed age-dependent immune dysregulation at the transcriptional, protein and cellular levels, manifesting in an imbalance of inflammatory responses over the course of hospitalization, and suggesting potential new therapeutic targets.

Infectious Diseases (except HIV/AIDS)
COVID-19 and cellular senescence

Clemens A. Schmitt,Tamar Tchkonia,Laura J. Niedernhofer,Paul D. Robbins,James L. Kirkland,Soyoung Lee

DOI: https://doi.org/10.1038/s41577-022-00785-2

IF: 108.555

2022-10-06

Nature Reviews Immunology

Abstract:The clinical severity of coronavirus disease 2019 (COVID-19) is largely determined by host factors. Recent advances point to cellular senescence, an ageing-related switch in cellular state, as a critical regulator of SARS-CoV-2-evoked hyperinflammation. SARS-CoV-2, like other viruses, can induce senescence and exacerbates the senescence-associated secretory phenotype (SASP), which is comprised largely of pro-inflammatory, extracellular matrix-degrading, complement-activating and pro-coagulatory factors secreted by senescent cells. These effects are enhanced in elderly individuals who have an increased proportion of pre-existing senescent cells in their tissues. SASP factors can contribute to a 'cytokine storm', tissue-destructive immune cell infiltration, endothelialitis (endotheliitis), fibrosis and microthrombosis. SASP-driven spreading of cellular senescence uncouples tissue injury from direct SARS-CoV-2-inflicted cellular damage in a paracrine fashion and can further amplify the SASP by increasing the burden of senescent cells. Preclinical and early clinical studies indicate that targeted elimination of senescent cells may offer a novel therapeutic opportunity to attenuate clinical deterioration in COVID-19 and improve resilience following infection with SARS-CoV-2 or other pathogens.

immunology
Determinants of SARS-CoV-2 Receptor Gene Expression in Upper and Lower Airways

Hananeh Aliee,Florian Massip,Cancan Qi,Maria Stella de Biase,Jos van Nijnatten,Elin T. G. Kersten,Nazanin Z. Kermani,Basil Khuder,Judith M. Vonk,Roel C. H. Vermeulen,Margaret Neighbors,Gaik W. Tew,Michele A. Grimbaldeston,Nick H. T. ten Hacken,Sile Hu,Yike Guo,Xiaoyu Zhang,Kai Sun,Pieter S. Hiemstra,Bruce A. Ponder,Mika J. Makela,Kristiina Malmstrom,Robert C. Rintoul,Paul A. Reyfman,Fabian J. Theis,Corry-Anke Brandsma,Ian M. Adcock,Wim Timens,Cheng-Jian Xu,Maarten van den Berge,Roland F. Schwarz,Gerard H. Koppelman,M. C. Nawijn,Alen Faiz

DOI: https://doi.org/10.1111/all.15152

IF: 12.4

2022-01-01

Allergy

Abstract:The recent outbreak of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), has led to a worldwide pandemic. One week after initial symptoms develop, a subset of patients progresses to severe disease, with high mortality and limited treatment options. To design novel interventions aimed at preventing spread of the virus and reducing progression to severe disease, detailed knowledge of the cell types and regulating factors driving cellular entry is urgently needed. Here we assess the expression patterns in genes required for COVID-19 entry into cells and replication, and their regulation by genetic, epigenetic and environmental factors, throughout the respiratory tract using samples collected from the upper (nasal) and lower airways (bronchi). Matched samples from the upper and lower airways show a clear increased expression of these genes in the nose compared to the bronchi and parenchyma. Cellular deconvolution indicates a clear association of these genes with the proportion of secretory epithelial cells. Smoking status was found to increase the majority of COVID-19 related genes including ACE2 and TMPRSS2 but only in the lower airways, which was associated with a significant increase in the predicted proportion of goblet cells in bronchial samples of current smokers. Both acute and second hand smoke were found to increase ACE2 expression in the bronchus. Inhaled corticosteroids decrease ACE2 expression in the lower airways. No significant effect of genetics on ACE2 expression was observed, but a strong association of DNA- methylation with ACE2 and TMPRSS2- mRNA expression was identified in the bronchus.

Aged nasal epithelium is more prone to severe COVID-19

Immune cell residency in the nasal mucosa may partially explain respiratory disease severity across the age range

Age-specific nasal epithelial responses to SARS-CoV-2 infection

SARS-CoV-2, COVID-19 and the aging immune system

Role of Aging and the Immune Response to Respiratory Viral Infections: Potential Implications for COVID-19

Aging, inflammaging and immunosenescence as risk factors of severe COVID-19

Age-related Differences in the Nasal Mucosal Immune Response to SARS-CoV-2

SARS-CoV-2 infection represents a high risk for the elderly: analysis of pathogenesis

COVID‐19 is an emergent disease of aging

Aging is associated with an insufficient early inflammatory response of lung endothelial cells in SARS-CoV-2 infection

Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?

Changes in the innate immune response to SARS-CoV-2 with advancing age in humans

Aging shapes infection profiles of influenza A virus and SARS-CoV-2 in human lung slices

Why does COVID-19 disproportionately affect older people?

Immune cell population and cytokine profiling suggest age dependent differences in the response to SARS-CoV-2 infection

Why Does the Severity of COVID-19 Differ With Age?: Understanding the Mechanisms Underlying the Age Gradient in Outcome Following SARS-CoV-2 Infection

Environmentally persistent free radicals enhance SARS-CoV-2 replication in respiratory epithelium

Evidence That SARS-CoV-2 Induces Lung Cell Senescence: Potential Impact on COVID-19 Lung Disease

Host-Microbe Multiomic Profiling Reveals Age-Dependent COVID-19 Immunopathology

COVID-19 and cellular senescence

Determinants of SARS-CoV-2 Receptor Gene Expression in Upper and Lower Airways